Ty McClure
Wave Life Sciences (United States)(US)
Publications by Year
Research Areas
TGF-β signaling in diseases, Cancer, Hypoxia, and Metabolism, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Immunotherapy and Immune Responses
Most-Cited Works
- → Myostatin inhibitor ACE‐031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo‐controlled clinical trial(2016)223 cited
- → A phase 1 study of ACE‐536, a regulator of erythroid differentiation, in healthy volunteers(2014)106 cited
- → Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial(2011)64 cited
- → Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor–like Kinase-1 Ligand Trap, in Patients with Advanced Cancer(2013)59 cited
- → Effects of molybdenum intake on primary infection and subsequent challenge by the nematode parasiteTrichostrongylus colubriformisin weaned Merino lambs(1999)31 cited
- → ICONIC: Biologic and clinical activity of first in class ICOS agonist antibody JTX-2011 +/- nivolumab (nivo) in patients (pts) with advanced cancers.(2018)30 cited
- → Abstract CT234: A phase I study of MM-302, a HER2-targeted PEGylated liposomal doxorubicin, in patients with HER2+ metastatic breast cancer(2015)29 cited
- → An investigation of the fertility of a random sample of waikato dairy herds(1959)14 cited
- → Pathology of brucellosis in rams in New Zealand(1955)14 cited
- → Absorption of Anti-Nematode Antibodies from Ewe's Colostrum by the New-born Lamb(1951)13 cited